Pronóstico del mercado europeo de dispositivos de neuroestimulación hasta 2030 – Análisis regional – por producto (estimulador de la médula espinal, estimulador cerebral profundo, estimulador del nervio sacro, estimulador del nervio vago y otros), aplicación (manejo del dolor, epilepsia, incontinencia urinaria y fecal, Parkinson) Enfermedades y Otros) y Usuario Final (Hospitales, Clínicas Especializadas y Otros)

BMIRE00030035 | Pages: 91 | Medical Device | Apr 2024 | Type: Regional | Status: Published
El mercado europeo de dispositivos de neuroestimulación estaba valorado en 1.717,84 millones de dólares en 2022 y se espera que alcance los 3.459,24 millones de dólares en 2030; se estima que registrará una tasa compuesta anual del 9,1% entre 2022 y 2030. Los crecientes casos de lesiones de la médula espinal impulsan el mercado europeo de dispositivos de neuroestimulación La industria de los dispositivos de neuroestimulación ha ganado fuerza debido al aumento de la población de edad avanzada propensa a diversos trastornos de la columna. Esta población se está volviendo más susceptible a desarrollar trastornos de la columna, como enfermedades degenerativas del disco, osteoartritis, escoliosis, tumores espinales y estenosis espinal. A medida que esta población envejece, el desgaste natural de la columna puede provocar varios trastornos de la columna. Por lo tanto, con este hecho, el envejecimiento de la población plantea un desafío único para los cirujanos de columna debido al aumento múltiple de la fragilidad, las comorbilidades médicas, el deterioro del estado nutricional y la mayor probabilidad de complicaciones posoperatorias. Según datos de la Organización Mundial de la Salud (OMS) publicados en octubre de 2022, aproximadamente el 80% de la población de edad avanzada vivirá en países de ingresos bajos y medios en 2050, y se prevé que el ritmo de envejecimiento de esta población será mucho mayor. más rápido que en el pasado. El envejecimiento demográfico, junto con factores relacionados con el estilo de vida, ha provocado un aumento sustancial de personas que experimentan problemas de columna, como enfermedades degenerativas del disco y deformidades de la columna. Por tanto, la alta incidencia de lesiones de la médula espinal en la vejez y en los adultos estimula la demanda de dispositivos de neuroestimulación. Descripción general del mercado europeo de dispositivos de neuroestimulación El mercado europeo de dispositivos de neuroestimulación está segmentado en el Reino Unido, Alemania, Francia, Italia, España y el resto de Europa. Se espera que el mercado regional crezca significativamente en los próximos años debido a la creciente prevalencia de trastornos neurológicos como aneurismas cerebrales, accidentes cerebrovasculares y otros y al aumento de las innovaciones de productos realizadas por los actores del mercado que operan en la región. El crecimiento del mercado también se atribuye al desarrollo de sistemas sanitarios en países como Alemania, Francia y España y al aumento de los lanzamientos de productos innovadores por parte de empresas regionales clave. En junio de 2020, Medtronic anunció el lanzamiento del neuroestimulador para PC PerceptTM con tecnología BrainsenseTM. La tecnología registra y envía simultáneamente estimulaciones eléctricas al cerebro para aliviar los síntomas de la enfermedad de Parkinson (EP). Ingresos del mercado europeo de dispositivos de neuroestimulación y pronóstico hasta 2030 (millones de dólares estadounidenses) Segmentación del mercado europeo de dispositivos de neuroestimulación El mercado europeo de dispositivos de neuroestimulación está segmentado según el producto, la aplicación, el usuario final y el país. Según el producto, el mercado europeo de dispositivos de neuroestimulación se segmenta en estimulador de la médula espinal, estimulador cerebral profundo, estimulador del nervio sacro, estimulador del nervio vago y otros. El segmento de estimuladores de médula espinal tuvo la mayor cuota de mercado en 2022. En términos de aplicación, el mercado europeo de dispositivos de neuroestimulación se clasifica en tratamiento del dolor, epilepsia, incontinencia urinaria y fecal, enfermedad de Parkinson y otros. El segmento de tratamiento del dolor tuvo la mayor cuota de mercado en 2022. Por usuario final, el mercado europeo de dispositivos de neuroestimulación se segmenta en hospitales, clínicas especializadas y otros. El segmento de hospitales tuvo la mayor cuota de mercado en 2022. Según el país, el mercado europeo de dispositivos de neuroestimulación está segmentado en el Reino Unido, Alemania, Francia, Italia, España y el resto de Europa. Alemania dominó la cuota de mercado europea de dispositivos de neuroestimulación en 2022. Medtronic Plc, Boston Scientific Corp, Abbott Laboratories, Nevro Corp, LivaNova Plc, Synapse Biomedical Inc, ElectroCore Inc y Mainstay Medical son algunas de las empresas líderes que operan en el mercado europeo de dispositivos de neuroestimulación. .
Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Neurostimulation Devices Market - Key Industry Dynamics

4.1 Market Drivers

4.1.1 Increasing Prevalence of Neurological Disorders

4.1.2 Rising Cases of Spinal Cord Injury

4.2 Market Restraints

4.2.1 Lack of Expert Professionals

4.3 Market Opportunities

4.3.1 Growing Advances and Approvals for Neurostimulation Devices

4.4 Future Trends

4.4.1 Rising Demand for Noninvasive Treatment

4.5 Impact Analysis

5. Neurostimulation Devices Market - Europe Market Analysis

5.1 Europe Neurostimulation Devices Market Revenue (US$ Mn), 2022 - 2030

6. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Product

6.1 Overview

6.2 Europe Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)

6.3 Spinal Cord Stimulator

6.3.1 Overview

6.3.2 Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Deep Brain Stimulator

6.4.1 Overview

6.4.2 Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

6.5 Sacral Nerve Stimulator

6.5.1 Overview

6.5.2 Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

6.6 Vagus Nerve Stimulator

6.6.1 Overview

6.6.2 Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

6.7 Others

6.7.1 Overview

6.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Application

7.1 Overview

7.2 Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)

7.3 Pain Management

7.3.1 Overview

7.3.2 Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Epilepsy

7.4.1 Overview

7.4.2 Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7.5 Urinary and Fecal Incontinence

7.5.1 Overview

7.5.2 Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7.6 Parkinson's Disease

7.6.1 Overview

7.6.2 Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7.7 Others

7.7.1 Overview

7.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - by End User

8.1 Overview

8.2 Europe Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)

8.3 Hospitals

8.3.1 Overview

8.3.2 Hospitals: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Specialty Clinics

8.4.1 Overview

8.4.2 Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Others

8.5.1 Overview

8.5.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - Country Analysis

9.1 Europe: Neurostimulation Devices Market

9.1.1 Overview

9.1.2 Europe: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)

9.1.2.1 Germany: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.2 Germany: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.2.1 Germany: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.2.2 Germany: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.2.3 Germany: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

9.1.2.3 UK: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.4 UK: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.4.1 UK: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.4.2 UK: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.4.3 UK: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

9.1.2.5 France: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.6 France: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.6.1 France: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.6.2 France: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.6.3 France: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

9.1.2.7 Italy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.8 Italy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.8.1 Italy: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.8.2 Italy: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.8.3 Italy: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

9.1.2.9 Spain: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.10 Spain: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.10.1 Spain: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.10.2 Spain: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.10.3 Spain: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

9.1.2.11 Rest of Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.12 Rest of Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.12.1 Rest of Europe: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.12.2 Rest of Europe: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.12.3 Rest of Europe: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

10. Neurostimulation Devices Market-Industry Landscape

10.1 Overview

10.2 Organic Developments

10.2.1 Overview

10.3 Inorganic Developments

10.3.1 Overview

11. Company Profiles

11.1 Medtronic Plc

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Boston Scientific Corp

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Abbott Laboratories

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Nevro Corp

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 LivaNova Plc

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Synapse Biomedical Inc.

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 ElectroCore Inc

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Mainstay Medical

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

12. Appendix

12.1 About Us

12.2 Glossary of Terms

List of Tables

Table 1. Neurostimulation Devices Market Segmentation

Table 2. Germany Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 3. Germany Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 4. Germany Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 5. UK Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 6. UK Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 7. UK Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 8. France Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 9. France Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 10. France Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 11. Italy Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 12. Italy Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 13. Italy Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 14. Spain Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 15. Spain Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 16. Spain Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 17. Rest of Europe Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 18. Rest of Europe Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 19. Rest of Europe Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 20. Organic Developments Done by Companies

Table 21. Inorganic Developments Done by Companies

Table 22. Glossary of Terms, Neurostimulation Devices Market

List of Figures

Figure 1. Neurostimulation Devices Market Segmentation, By Country

Figure 2. Neurostimulation Devices Market: Key Industry Dynamics

Figure 3. Neurostimulation Devices Market: Impact Analysis of Drivers and Restraints

Figure 4. Europe Neurostimulation Devices Market Revenue (US$ Mn), 2020 - 2030

Figure 5. Europe Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)

Figure 6. Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)

Figure 12. Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Europe Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)

Figure 18. Hospitals & Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. Europe: Neurostimulation Devices Market, by Key Country - Revenue (2022) (US$ Million)

Figure 22. Europe: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)

Figure 23. Germany: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 24. UK: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 25. France: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 26. Italy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 27. Spain: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 28. Rest of Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

1. Medtronic Plc

2. Boston Scientific Corp

3. Abbott Laboratories

4. Nevro Corp

5. LivaNova Plc

6. Synapse Biomedical Inc

7. ElectroCore Inc

8. Mainstay Medical

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe neurostimulation devices market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe neurostimulation devices market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe neurostimulation devices market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
  • Report Code
    Full Name
    Country Name
    Email Id
    Phone Number
    Job Title
    Company
    Requirement

    Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


    Purchase Options
    Single User License
    $3550
    $2840
    Site License
    $4550
    $3640
    Enterprise License
    $5550
    $4440